Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion.

Balaskas, Konstantinos; Amoaku, Winfried M; Cudrnak, Tomas; Downey, Louise M; Groppe, Markus; Mahmood, Sajjad; Mehta, Hemal; Mohamed, Quresh; Mushtaq, Bushra; Severn, Philip; Vardarinos, Athanasios; Yang, Yit C.

Afiliação

Balaskas K; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and University College of London Institute of Ophthalmology, London, UK. k.balaskas@nhs.net.
Amoaku WM; Academic Ophthalmology, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
Cudrnak T; Royal Eye Infirmary, University Hospitals Plymouth NHS Trust, Plymouth, UK.
Downey LM; Hull University Teaching Hospital, Hull, UK.
Groppe M; Ophthalmology, Stoke Mandeville, Buckinghamshire Healthcare NHS Trust, Aylesbury, UK.
Mahmood S; Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Mehta H; Royal Free London NHS Foundation Trust, London, UK.
Mohamed Q; Gloucestershire Eye Unit, Cheltenham General Hospital, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
Mushtaq B; Birmingham and Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham, UK.
Severn P; South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
Vardarinos A; Eye Treatment Centre, West Suffolk Hospital, West Suffolk NHS Foundation Trust, Bury St Edmunds, UK.
Yang YC; Wolverhampton Eye Infirmary, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.